Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity.

Spencer HL, Jover E, Cathery W, Avolio E, Rodriguez-Arabaolaza I, Thomas AC, Alvino VV, Sala-Newby G, Dang Z, Fagnano M, Reni C, Rowlinson J, Vono R, Spinetti G, Beltrami AP, Gargioli C, Caporali A, Angelini G, Madeddu P.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1113-1124. doi: 10.1161/ATVBAHA.119.312665.

PMID:
31018661
2.

Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease.

Jover E, Fagnano M, Angelini G, Madeddu P.

Front Cardiovasc Med. 2018 Nov 6;5:155. doi: 10.3389/fcvm.2018.00155. eCollection 2018. Review.

3.

MicroRNA-532-5p Regulates Pericyte Function by Targeting the Transcription Regulator BACH1 and Angiopoietin-1.

Slater SC, Jover E, Martello A, Mitić T, Rodriguez-Arabaolaza I, Vono R, Alvino VV, Satchell SC, Spinetti G, Caporali A, Madeddu P.

Mol Ther. 2018 Dec 5;26(12):2823-2837. doi: 10.1016/j.ymthe.2018.08.020. Epub 2018 Sep 1.

4.

Genetic counseling in an indigenous Filipino community with a high prevalence of A2ML1-related otitis media.

la Paz EMC, Pedro M, Yarza TKL, Lagrana-Villagracia SM, Amoranto AJP, Jover EJM, Domine MTB, Chiong CM, Santos-Cortez RLP.

J Community Genet. 2019 Jan;10(1):143-151. doi: 10.1007/s12687-018-0368-2. Epub 2018 Jun 15.

5.

Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification.

Jover E, Silvente A, Marín F, Martínez-González J, Orriols M, Martinez CM, Puche CM, Valdés M, Rodriguez C, Hernández-Romero D.

FASEB J. 2018 Aug;32(8):4459-4469. doi: 10.1096/fj.201700653R. Epub 2018 Mar 16.

PMID:
29547702
6.

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation.

Tello-Montoliu A, Rivera J, Hernández D, Silvente A, Jover E, Rodriguez AI, Quintana M, Romero A, Orenes-Piñero E, Rivera-Caravaca JM, Marín F, Veliz A, Valdés M.

Circ J. 2018 Jan 25;82(2):353-360. doi: 10.1253/circj.CJ-17-0471. Epub 2017 Sep 6.

7.

Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin.

Zimmermann-Meisse G, Prévost G, Jover E.

Toxins (Basel). 2017 Jan 20;9(1). pii: E41. doi: 10.3390/toxins9010041.

8.

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

Hernández-Romero D, Vílchez JA, Lahoz Á, Romero-Aniorte AI, Jover E, García-Alberola A, Jara-Rubio R, Martínez CM, Valdés M, Marín F.

Sci Rep. 2017 Jan 12;7:40378. doi: 10.1038/srep40378.

9.

Silk-Fibroin and Graphene Oxide Composites Promote Human Periodontal Ligament Stem Cell Spontaneous Differentiation into Osteo/Cementoblast-Like Cells.

Vera-Sánchez M, Aznar-Cervantes S, Jover E, García-Bernal D, Oñate-Sánchez RE, Hernández-Romero D, Moraleda JM, Collado-González M, Rodríguez-Lozano FJ, Cenis JL.

Stem Cells Dev. 2016 Nov 15;25(22):1742-1754. Epub 2016 Aug 8.

PMID:
27503546
10.

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.

Tello-Montoliu A, Rivera J, Hernández-Romero D, Silvente A, Jover E, Quintana M, Orenes-Piñero E, Hurtado J, Ferreiro JL, Marín F, Valdés M.

Platelets. 2016 Dec;27(8):777-783. Epub 2016 Jun 2.

PMID:
27257022
11.

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.

Hernández-Romero D, Lahoz Á, Roldan V, Jover E, Romero-Aniorte AI, Martinez CM, Jara-Rubio R, Arribas JM, Garcia-Alberola A, Cánovas S, Valdés M, Marín F.

Europace. 2016 Sep;18(9):1328-34. doi: 10.1093/europace/euv354. Epub 2015 Nov 12.

PMID:
26566941
12.

CALU polymorphism A29809G affects calumenin availability involving vascular calcification.

Jover E, Marín F, Quintana M, Pérez-Andreu J, Hurtado JA, Rodríguez C, Martínez-González J, González-Conejero R, Valdés M, Hernández-Romero D.

J Mol Cell Cardiol. 2015 May;82:218-27. doi: 10.1016/j.yjmcc.2015.03.015. Epub 2015 Mar 28.

PMID:
25823396
13.

Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca(2+) mobilization by human neutrophils.

Tawk MY, Zimmermann-Meisse G, Bossu JL, Potrich C, Bourcier T, Dalla Serra M, Poulain B, Prévost G, Jover E.

Cell Microbiol. 2015 Aug;17(8):1241-57. doi: 10.1111/cmi.12434. Epub 2015 Mar 30.

PMID:
25737084
14.

TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy.

Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F.

Eur J Clin Invest. 2015 Feb;45(2):179-86. doi: 10.1111/eci.12394. Epub 2015 Jan 7.

PMID:
25524713
15.

R-type calcium channels are crucial for semaphorin 3A-induced DRG axon growth cone collapse.

Treinys R, Kaselis A, Jover E, Bagnard D, Šatkauskas S.

PLoS One. 2014 Jul 17;9(7):e102357. doi: 10.1371/journal.pone.0102357. eCollection 2014.

16.

The 14th EuCheMS International Conference on Chemistry and the Environment (ICCE 2013, Barcelona, June 25-28, 2013).

Luis SV, Jover E.

Environ Sci Pollut Res Int. 2014 Oct;21(20):11611-3. doi: 10.1007/s11356-014-3193-0. Epub 2014 Jun 20. No abstract available.

PMID:
24946710
17.

Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin.

Montoro-García S, Shantsila E, Hernández-Romero D, Jover E, Valdés M, Marín F, Lip GY.

Br J Haematol. 2014 Aug;166(4):571-80. doi: 10.1111/bjh.12913. Epub 2014 Apr 28.

PMID:
24766273
18.

High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.

Jover E, Rodríguez JM, Bernal A, Arroyo AB, Iniesta JA, Guiú IS, Martínez C, Vicente V, Lozano ML, Rivera J.

Blood Coagul Fibrinolysis. 2014 Sep;25(6):604-11. doi: 10.1097/MBC.0000000000000118.

PMID:
24717421
19.

14th EuCheMS International Conference on Chemistry and the Environment ICCE 2013: IEC-WTC, Barcelona, Spain, 25-28 June 2013.

Luis SV, Jover E.

Environ Sci Pollut Res Int. 2014 Oct;21(20):11933-7. doi: 10.1007/s11356-014-2756-4. Epub 2014 Apr 2.

PMID:
24691932
20.

Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface.

Laventie BJ, Guérin F, Mourey L, Tawk MY, Jover E, Maveyraud L, Prévost G.

PLoS One. 2014 Mar 18;9(3):e92094. doi: 10.1371/journal.pone.0092094. eCollection 2014.

21.

Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.

Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F.

Stroke. 2014 Mar;45(3):696-701. doi: 10.1161/STROKEAHA.113.003338. Epub 2014 Feb 11.

PMID:
24519407
22.

[New antiplatelet drugs in coronary artery disease].

Tello-Montoliu A, Jover E, Valdés M.

Med Clin (Barc). 2014 Dec 9;143(11):508-14. doi: 10.1016/j.medcli.2013.12.006. Epub 2014 Jan 28. Review. Spanish.

PMID:
24480290
23.

Water plasma functionalized CNTs/MnO2 composites for supercapacitors.

Hussain S, Amade R, Jover E, Bertran E.

ScientificWorldJournal. 2013 Nov 19;2013:832581. doi: 10.1155/2013/832581. eCollection 2013.

24.

The prognostic role of the adiponectin levels in atrial fibrillation.

Hernández-Romero D, Jover E, Marín F, Vilchez JA, Manzano-Fernandez S, Romera M, Vicente V, Valdés M, Lip GY, Roldán V.

Eur J Clin Invest. 2013 Feb;43(2):168-73. doi: 10.1111/eci.12028. Epub 2012 Dec 20. Erratum in: Eur J Clin Invest. 2013 Apr;43(4):428.

PMID:
23278336
25.

Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

Jover E, Marín F, Roldán V, Montoro-García S, Valdés M, Lip GY.

Ann Med. 2013 May;45(3):274-90. doi: 10.3109/07853890.2012.732702. Epub 2012 Dec 8. Review.

PMID:
23216106
26.

Staphylococcal leukotoxins trigger free intracellular Ca(2+) rise in neurones, signalling through acidic stores and activation of store-operated channels.

Jover E, Tawk MY, Laventie BJ, Poulain B, Prévost G.

Cell Microbiol. 2013 May;15(5):742-58. doi: 10.1111/cmi.12069. Epub 2012 Dec 6.

27.

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.

Gallego P, Roldán V, Marín F, Jover E, Manzano-Fernández S, Valdés M, Vicente V, Lip GY.

Eur J Clin Invest. 2012 Dec;42(12):1302-8. doi: 10.1111/eci.12004. Epub 2012 Oct 11.

PMID:
23057651
28.

Vertically aligned carbon nanotubes for microelectrode arrays applications.

Castro Smirnov JR, Jover E, Amade R, Gabriel G, Villa R, Bertran E.

J Nanosci Nanotechnol. 2012 Sep;12(9):6941-7.

PMID:
23035418
29.

Serum adiponectin level as a biomarker of coronary artery calcification and severe coronary lesions.

Jover E, Hernández-Romero D, Hurtado JA, Romero-Aniorte AI, Casas T, Valdés M.

Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):1060-1. doi: 10.1016/j.recesp.2012.03.031. Epub 2012 Sep 7. English, Spanish. No abstract available.

PMID:
22964061
30.

Functionalization of carbon nanotubes by water plasma.

Hussain S, Amade R, Jover E, Bertran E.

Nanotechnology. 2012 Sep 28;23(38):385604. doi: 10.1088/0957-4484/23/38/385604. Epub 2012 Sep 4.

PMID:
22947598
31.

High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.

Roldán V, Marín F, Díaz J, Gallego P, Jover E, Romera M, Manzano-Fernández S, Casas T, Valdés M, Vicente V, Lip GY.

J Thromb Haemost. 2012 Aug;10(8):1500-7. doi: 10.1111/j.1538-7836.2012.04812.x.

32.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish.

PMID:
22609214
33.

New perspectives in antiplatelet therapy.

Tello-Montoliu A, Jover E, Rivera J, Valdés M, Angiolillo DJ, Marín F.

Curr Med Chem. 2012;19(3):406-27. Review.

PMID:
22335515
34.

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.

Montoro-García S, Hernández-Romero D, Jover E, García-Honrubia A, Vilchez JA, Casas T, Martínez P, Climent V, Caballero L, Valdés M, Marín F.

Eur J Intern Med. 2012 Mar;23(2):169-74. doi: 10.1016/j.ejim.2011.08.022. Epub 2011 Sep 15.

PMID:
22284249
35.

Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome.

Tello-Montoliu A, Jover E, Marín F, Bernal A, Lozano ML, Sánchez-Vega B, Pastor FJ, Hurtado JA, Valdés M, Vicente V, Rivera J.

Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):219-26. doi: 10.1016/j.recesp.2011.07.013. Epub 2011 Nov 23. English, Spanish.

PMID:
22116003
36.

Interactions between clopidogrel and proton pump inhibitors: a review of evidence.

Muñoz-Esparza C, Jover E, Hernández-Romero D, Saura D, Valdés M, Lip GY, Marín F.

Curr Med Chem. 2011;18(16):2386-400. Review.

PMID:
21568918
37.

An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.

Orenes-Piñero E, Hernández-Romero D, Jover E, de la Morena G, Valdés M, Marín F.

Med Chem. 2011 Jul;7(4):275-85. Review.

PMID:
21568880
38.

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.

Orenes-Piñero E, Hernández-Romero D, Jover E, Valdés M, Lip GY, Marín F.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):521-30. doi: 10.1177/1470320311405247. Epub 2011 Apr 20. Review.

PMID:
21507890
39.

A label-free biosensor assay for botulinum neurotoxin B in food and human serum.

Ferracci G, Marconi S, Mazuet C, Jover E, Blanchard MP, Seagar M, Popoff M, Lévêque C.

Anal Biochem. 2011 Mar 15;410(2):281-8. doi: 10.1016/j.ab.2010.11.045. Epub 2010 Dec 4.

PMID:
21134347
40.

Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Lonchamp E, Dupont JL, Wioland L, Courjaret R, Mbebi-Liegeois C, Jover E, Doussau F, Popoff MR, Bossu JL, de Barry J, Poulain B.

PLoS One. 2010 Sep 30;5(9). pii: e13046. doi: 10.1371/journal.pone.0013046.

41.

Quantification and source identification of polycyclic aromatic hydrocarbons in core sediments from Sundarban mangrove wetland, India.

Domínguez C, Sarkar SK, Bhattacharya A, Chatterjee M, Bhattacharya BD, Jover E, Albaigés J, Bayona JM, Alam MA, Satpathy KK.

Arch Environ Contam Toxicol. 2010 Jul;59(1):49-61. doi: 10.1007/s00244-009-9444-2. Epub 2010 Jan 16.

PMID:
20082069
42.

Occurrence and fate of benzothiazoles and benzotriazoles in constructed wetlands.

Matamoros V, Jover E, Bayona JM.

Water Sci Technol. 2010;61(1):191-8. doi: 10.2166/wst.2010.797.

PMID:
20057105
44.

Assessment of the emission of PCDD/Fs and dioxin-like PCBs from an industrial area over a nearby town using a selective wind direction sampling device.

Martínez K, Austrui JR, Jover E, Abalos M, Rivera J, Abad E.

Environ Pollut. 2010 Mar;158(3):764-9. doi: 10.1016/j.envpol.2009.10.011. Epub 2009 Nov 8.

PMID:
19897294
45.

Photo-solid-phase microextraction of selected indoor air pollutants from office buildings. Identification of their photolysis intermediates.

Fernandez-Alvarez M, Lores M, Jover E, Garcia-Jares C, Bayona JM, Llompart M.

J Chromatogr A. 2009 Dec 18;1216(51):8969-78. doi: 10.1016/j.chroma.2009.10.047. Epub 2009 Oct 20.

PMID:
19896136
46.
47.

[Mechanisms of action of botulinum toxins and neurotoxins].

Poulain B, Lonchamp E, Jover E, Popoff MR, Molgó J.

Ann Dermatol Venereol. 2009 May;136 Suppl 4:S73-6. doi: 10.1016/S0151-9638(09)74531-4. Review. French.

PMID:
19576489
48.
49.

Allylnitrile metabolism by CYP2E1 and other CYPs leads to distinct lethal and vestibulotoxic effects in the mouse.

Boadas-Vaello P, Jover E, Saldaña-Ruíz S, Soler-Martín C, Chabbert C, Bayona JM, Llorens J.

Toxicol Sci. 2009 Feb;107(2):461-72. doi: 10.1093/toxsci/kfn233. Epub 2008 Nov 6.

50.

Advances in the determination of degradation intermediates of personal care products in environmental matrixes: a review.

Matamoros V, Jover E, Bayona JM.

Anal Bioanal Chem. 2009 Feb;393(3):847-60. doi: 10.1007/s00216-008-2371-7. Epub 2008 Sep 20. Review.

PMID:
18807019

Supplemental Content

Support Center